Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

XENEXENE
Showing 8 of 14 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in XENON PHARMACEUTICALS INC

WELLINGTON MANAGEMENT GROUP LLP holds 1.4M shares of XENE (XENON PHARMACEUTICALS INC), worth $86M as of 2026-Q2. The position was decreased (-70.5% shares). XENE represents 0.0% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$86M

Current Shares

1.4M

Total Value Change

-$65.3M

Total Shares Change

-2.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.4M
-70.5%
$86M0.0%$60.36
0
2026-Q1
Increased
4.8M
+1.4%
$280.8M0.1%$43.79
31
2025-Q4
Increased
4.8M
+32.0%
$213.6M0.0%$44.12
39
2025-Q3
Increased
3.6M
+66.0%
$144.9M0.0%$39.06
44
2025-Q2
Decreased
2.2M
-42.6%
$68.1M0.0%$32.40
0
2025-Q1
Increased
3.8M
+0.3%
$127.1M0.0%$34.26
30
2024-Q4
Decreased
3.8M
-1.7%
$148.1M0.0%$38.53
0
2024-Q3
Increased
3.8M
+0.4%
$151.3M0.0%$38.65
30

Other major holders of XENE: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used